Unknown

Dataset Information

0

Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos.


ABSTRACT: Third-generation aromatase inhibitors such as anastrozole (ATZ) and letrozole (LTZ) are widely used to treat estrogen receptor-positive ER+ breast cancers in postmenopausal women. Investigating their ability to coordinate metals could lead to the emergence of a new category of anticancer drug candidates with a broader spectrum of pharmacological activities. In this study, a series of ruthenium (II) arene complexes bearing the aromatase inhibitor anastrozole was synthesized and characterized. Among these complexes, [Ru(? 6 -C6H6)(PPh3)(? 1 -ATZ)Cl]BPh4 (3) was found to be the most stable in cell culture media, to lead to the highest cellular uptake and in vitro cytotoxicity in two ER+ human breast cancer cell lines (MCF7 and T47D), and to induce a decrease in aromatase activity in H295R cells. Exposure of zebrafish embryos to complex 3 (12.5 ?M) did not lead to noticeable signs of toxicity over 96 h, making it a suitable candidate for further in vivo investigations.

SUBMITTER: Golbaghi G 

PROVIDER: S-EPMC6874409 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, <i>in Vitro</i> Biological Activity and <i>in Vivo</i> Toxicity in Zebrafish Embryos.

Golbaghi Golara G   Haghdoost Mohammad Mehdi MM   Yancu Debbie D   Santos Yossef López de Los YLL   Doucet Nicolas N   Patten Shunmoogum A SA   Sanderson J Thomas JT   Castonguay Annie A  

Organometallics 20190131 3


Third-generation aromatase inhibitors such as anastrozole (ATZ) and letrozole (LTZ) are widely used to treat estrogen receptor-positive ER+ breast cancers in postmenopausal women. Investigating their ability to coordinate metals could lead to the emergence of a new category of anticancer drug candidates with a broader spectrum of pharmacological activities. In this study, a series of ruthenium (II) arene complexes bearing the aromatase inhibitor anastrozole was synthesized and characterized. Amo  ...[more]

Similar Datasets

| S-EPMC3515875 | biostudies-literature
| S-EPMC2846641 | biostudies-literature
| S-EPMC6154573 | biostudies-literature
| S-EPMC3418082 | biostudies-other
| S-EPMC5992061 | biostudies-literature
| S-EPMC3854648 | biostudies-literature
| S-EPMC6062322 | biostudies-literature
| S-EPMC3940891 | biostudies-literature
| S-EPMC8707050 | biostudies-literature
| S-EPMC3203771 | biostudies-other